Regarding metabolic disorders, PGC-1α mRNA levels are reduced in certain cohorts of obese and type 2 diabetic individuals [25, 26], and, in some populations, polymorphisms in the PGC-1α gene have been linked to a predisposition for type 2 diabetes [41, 42]. Here, PPARGC1A is linked to metabolic disease.